-

Allscripts and US Orthopedic Alliance Expand Strategic Partnership, Ushering in ‘The Gold Standard’ For Orthopedic Technology Platforms

CHICAGO--(BUSINESS WIRE)--Allscripts Healthcare Solutions (NASDAQ: MDRX) today announced a strategic technology partnership with US Orthopedic Alliance (USOA), an orthopedic management services provider based in Southern California, to support USOA’s growth and pursue additional relationships with leading orthopedic providers nationwide. The partnership will bring to market best-of-breed infrastructure designed to help orthopedic practices scale with agility, improve EHR implementation timelines, provide evidence-based guidelines to support evolving clinical protocols, and create community-wide connectivity with value-based care analytics.

The selection of USOA’s proprietary, data-driven platform is the result of an expansive vetting process of orthopedic management services providers by the Allscripts team.

"Combining the extensive industry expertise of USOA with Allscripts’ vast technology expertise and broad use in the independent physician space creates a compelling platform for orthopedic practitioners that want to access health information technology solutions only the largest health systems could afford," said Leah Jones, SVP and general manager of Allscripts’ ambulatory business unit. "We couldn't be more excited to work with the USOA team in building an exceptional, accessible, and scalable orthopedic services technology platform."

USOA currently provides industry-leading management services to a network of more than 100 orthopedic surgeons, 12 ambulatory surgery centers and one specialty hospital. Physician members benefit from USOA's superior business intelligence solutions, including revenue cycle management, contracting, risk management, and value-based care services such as infrastructure, technology, and data analytics.

"USOA has rapidly grown its market position by providing orthopedic practices with specialty-specific services to manage and grow their practice while enhancing the patient experience," said Rick Salas, chief executive officer of USOA. "Our network has been asking about USOA's ability to deliver an open, unifying and enabling technology platform to support independent orthopedic practices. The USOA/Allscripts deployment is an ideal fit for our network to support and empower their growth."

John Kang, chief strategy officer of USOA, added, “Together, Allscripts and USOA are committed to supporting physicians to build profitable, patient-centric practices. We look forward to working closely with Allscripts’ team and its high-performing ambulatory business unit."

About Allscripts

Allscripts (NASDAQ: MDRX) is a leader in healthcare information technology solutions that advance clinical, financial and operational results. Our innovative solutions connect people, places and data across an Open, Connected Community of Health™. Connectivity empowers caregivers to make better decisions and deliver better care for healthier populations. To learn more, visit www.allscripts.com, Twitter, YouTube and It Takes a Community: The Allscripts Blog.

© 2021 Allscripts Healthcare, LLC and/or its affiliates. All Rights Reserved.

Allscripts, the Allscripts logo, and other Allscripts marks are trademarks of Allscripts Healthcare, LLC and/or its affiliates. All other products are trademarks of their respective holders, all rights reserved. Reference to these products is not intended to imply affiliation with or sponsorship of Allscripts Healthcare, LLC and/or its affiliates.

Contacts

Investors:
Stephen Shulstein
312-386-6735
stephen.shulstein@allscripts.com

Media:
Concetta Rasiarmos
312-447-2466
concetta.rasiarmos@allscripts.com

Allscripts

NASDAQ:MDRX

Release Versions
Hashtags

Contacts

Investors:
Stephen Shulstein
312-386-6735
stephen.shulstein@allscripts.com

Media:
Concetta Rasiarmos
312-447-2466
concetta.rasiarmos@allscripts.com

More News From Allscripts

Veradigm Provides Business and Strategy Update

CHICAGO--(BUSINESS WIRE)--Veradigm® (OTCMKTS: MDRX), a leading provider of clinical and revenue cycle solutions for independent practices, is providing estimated financial performance for the fiscal year 2025 and key areas of strategic focus for 2026. “On my first investor call in October, I committed to advancing three strategic objectives in my first 100 days: reset our business strategy, recover our market leadership with independent physician practices and reignite profitable growth,” said...

Veradigm Brings Patient Voice to Healthcare Research with New Real-World Data Survey Solution

CHICAGO--(BUSINESS WIRE)--Veradigm (OTCMKTS:MDRX), a leading provider of clinical and revenue cycle solutions for independent practices, today announced a new patient‑reported outcomes (PRO) survey capability that brings the patient voice directly into real‑world evidence generation. The new solution gives life sciences organizations timely, privacy‑preserving insights directly from patients, adding essential context to clinical and observational research. Built on Veradigm’s FollowMyHealth pat...

Veradigm to Release Business Update February 17th and Host Investor Call February 18th

CHICAGO--(BUSINESS WIRE)--Veradigm® (OTCMKTS: MDRX), a leading provider of clinical and revenue cycle solutions for independent practices, announced today that management plans to provide a business update after the close of regular stock market hours on February 17, 2026. Veradigm management plans to host an investor conference call and webcast to discuss the Company’s update at 8:00 a.m. Eastern Time on February 18, 2026. Update Call Details Veradigm plans to issue a press release after the c...
Back to Newsroom